Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2037655 | Cell | 2007 | 4 Pages |
Abstract
Inhibitor of apoptosis proteins (IAPs) such as XIAP, cIAP1, and cIAP2 are upregulated in many cancer cells. It has been thought that small-molecule mimetics of Smac, an endogenous IAP antagonist, might potentiate apoptosis in cancer cells by promoting caspase activation. However, three recent papers, two in Cell ( Vince et al., 2007 and Varfolomeev et al., 2007) and one in Cancer Cell ( Petersen et al., 2007), now report that Smac mimetics primarily kill cancer cells via a different mechanism, the induction of autoubiquitination and degradation of cIAPs, which culminates in TNFα-mediated cell death.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry, Genetics and Molecular Biology (General)
Authors
Hao Wu, Jurg Tschopp, Su-Chang Lin,